ACLARION, INC. Dividends, Preferred Stock
ACLARION, INC. (ACON) reported Dividends, Preferred Stock of $415.52 thousand for the 12-month period ending 2022-12-31, per its 10-K/A filed 2023-06-12.
Discontinued › Shareholders' Equity › Dividends › Dividends, Preferred Stock
us-gaap:DividendsPreferredStock · last filed 2023-06-12
- ACLARION, INC. dividends, preferred stock for the quarter ending 2022-12-31 was -$3.44M, a 1290.69% decline year-over-year.
- ACLARION, INC. dividends, preferred stock for the quarter ending 2021-12-31 was $289.02K.
- ACLARION, INC. dividends, preferred stock for fiscal 2022 was $415.52K, a 58.68% decline from fiscal 2021.
- ACLARION, INC. dividends, preferred stock for fiscal 2021 was $1.01M.
| Period end | Dividends, Preferred Stock 3 month | Dividends, Preferred Stock 9 month | Dividends, Preferred Stock 12 month |
|---|---|---|---|
| 2022-12-31 | -$3.44M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $415.52K 10-K/A · filed 2023-06-12 | |
| 2022-09-30 | $3.86M 10-Q · filed 2022-11-14 | ||
| 2021-12-31 | $289.02K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $1.01M 10-K/A · filed 2023-06-12 | |
| 2021-09-30 | $716.57K 10-Q · filed 2022-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |